As he begins his third bottle of Harvoni (sofosbuvir/ledipasvir), Jeff Roth discusses his experiences on Gilead Science’s blockbuster hepatitis C treatment. His journey has not been easy, but he is determined to see it through.
Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.
Comments
Comments